Camilla Kilbane, MD
- Assistant Professor
- Medical Director, Deep Brain Stimulation Program
- Interim Director, Parkinson’s and Movement Disorder Center
- Interim Director, Movement Disorders Center
Camilla Kilbane, MD, is a neurologist at University Hospitals Cleveland Medical Center and Assistant Professor of Neurology at Case Western Reserve University School of Medicine. She also directs the fellowship program in movement disorders in the Parkinson’s & Movement Disorders Center at UH Cleveland Medical Center.
Dr. Kilbane is board-certified in neurology and psychiatry. Her special interests include movement disorders, dystonia, Parkinson’s disease, deep brain stimulation (DBS), functional movement disorders, essential tremor and neurophysiology. She joined the UH Cleveland Medical Center staff in 2015, after two and a half years on staff at Stanford University Hospital.
Dr. Kilbane completed her medical degree at the Royal College of Surgeons in Dublin, Ireland, after receiving a national Norwegian scholarship to study abroad. She completed an internship at Beaumont Hospital in Dublin, Ireland, prior to moving to the U.S. She did a U.S. internship at Queens Hospital Center in Queens, N.Y. Dr. Kilbane completed her residency in neurology at Mount Sinai Medical Center in New York City, serving as chief resident, and completed two years of fellowship training in movement disorders at University of California San Francisco.
Dr. Kilbane participates in clinical trials of investigational drugs and devices to treat Parkinson’s disease and other movement disorders. She is the author or co-author of nearly a dozen publications in peer-reviewed medical journals. In addition, she has presented abstracts at many international and national peer-reviewed medical conferences. Dr. Kilbane is a member of the American Academy of Neurology and the Movement Disorder Society.
- Atypical Parkinsonism
- Deep Brain Stimulation
- Functional Movement Disorders
- Huntington's Disease
- Movement Disorders
- Parkinson's Disease
- Tourette's Syndrome
Patient Satisfaction Reviews
4.9 out of 5
Patient Comments (1)
Reviewed On 12/29/2018
initial visit with Dr. Kilbane for *****and could not have been more pleased with visit so far.
- Neurology - American Board of Psychiatry and Neurology
Fellowship | Movement Disorders
Movement Disorders - Ucsf Medical Center At Parnassus (2010 - 2012)
Residency | Neurology
Neurology - Mount Sinai Hospital (2007 - 2010)
Internship | Internal Medicine
Internal Medicine - Queens Hospital Center (2006 - 2007)
Royal College Of Surgeons In Ireland School Of Medicine (2004)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Camilla Kilbane did not disclose any Outside Relationships with Industry.